IQVIA is experiencing accelerating revenue growth, with 8.7% YoY growth in 2026Q2, driven by strong demand across its clinical and data segments. However, the company's profitability is under pressure from rising SG&A costs (up 12.8% YoY) and a mix shift towar...
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue growth accelerated to 8.7% YoY in 2026Q2, but gross margin contracted to 32.9% from 34.8% in 2024Q4, and SG&A outpaced revenue growth, limiting operating margin to 11.6%.
IQVIA accelerates innovation and improves patient outcomes through its advanced analytics and technology, helping life sciences organizations bring treatments to market faster.
The company has a wide moat, indicating strong competitive advantages and barriers to entry in its market.
Top holder Vanguard Group owns 11.4% of IQVIA, reflecting confidence from major institutional investors.
Trailing total returns as of 9/23/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Jul 28, 2026 | $3.15+4.0% vs $3.03 | $4.4B+1.5% vs $4.3B |
Q2 2026 May 5, 2026 | $2.90+2.8% vs $2.82 | $4.2B+1.2% vs $4.1B |
Q1 2026 Feb 5, 2026 | $3.42+0.6% vs $3.40 | $4.4B+2.9% vs $4.2B |
Q4 2025 Oct 28, 2025 | $3.00+0.7% vs $2.98 | $4.1B+0.5% vs $4.1B |
Bullfrog AI (NASDAQ: BFRG - Get Free Report) and IQVIA (NYSE: IQV - Get Free Report) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their risk, profitability, earnings, dividends, institutional ownership, analyst recommendations and valuation. Profitability This table compares Bullfrog AI and IQVIA's net
IQV's accelerating organic growth, robust R&DS bookings and expanding AI adoption are strengthening demand visibility and business momentum.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Arizona State Retirement System lifted its stake in IQVIA Holdings Inc. (NYSE: IQV) by 5.1% in the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 48,655 shares of the medical research company's stock after purchasing an additional 2,372 shares during the quarter. Arizona
Benchmark IQV against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for IQVIA Holdings Inc. (IQV)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $270.09 | $44.46B | 34.45 | 5.87% | 8.34% | 21.42% | — | |
| $285.11 | $13.73B | -97.98 | -0.85% | -5.96% | -7.63% | — | |
| $167.11 | $12.8B | 57.62 | -0.37% | 3.99% | 3.54% | — | |
| $25.00 | $1.29B | 25.25 | -2.67% | 6.04% | 4.95% | — | |
| $630.19 | $17.59B | 41.24 | 19.97% | 17.67% | 110.15% | — | |
| $260.91 | $42.38B | 47.96 | 16.34% | 29.34% | 14% | — |
IQVIA Holdings Inc. (IQV) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
IQVIA Holdings Inc. (IQV) SEC filings — annual & quarterly reports (10-K, 10-Q)
Jul 28, 2026·SEC
Jun 11, 2026·SEC
Jun 4, 2026·SEC
Get notified when IQV posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
IQVIA Holdings Inc. (IQV) stock FAQ — growth, dividends, profitability & financials explained
IQVIA Holdings Inc. (IQV) reported $16.98B in revenue for fiscal year 2025. This represents a 292% increase from $4.33B in 2011.
IQVIA Holdings Inc. (IQV) grew revenue by 5.9% over the past year. This is steady growth.
Yes, IQVIA Holdings Inc. (IQV) is profitable, generating $1.38B in net income for fiscal year 2025 (8.3% net margin).
IQVIA Holdings Inc. (IQV) has a return on equity (ROE) of 21.4%. This is excellent, indicating efficient use of shareholder capital.
IQVIA Holdings Inc. (IQV) generated $2.61B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
